BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 29430747)

  • 1. Left atrial rather than left ventricular impaired mechanics are associated with the pro-fibrotic ST2 marker and outcomes in heart failure with preserved ejection fraction.
    Nagy AI; Hage C; Merkely B; Donal E; Daubert JC; Linde C; Lund LH; Manouras A
    J Intern Med; 2018 Apr; 283(4):380-391. PubMed ID: 29430747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Santos AB; Roca GQ; Claggett B; Sweitzer NK; Shah SJ; Anand IS; Fang JC; Zile MR; Pitt B; Solomon SD; Shah AM
    Circ Heart Fail; 2016 Apr; 9(4):e002763. PubMed ID: 27056882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
    Kraigher-Krainer E; Shah AM; Gupta DK; Santos A; Claggett B; Pieske B; Zile MR; Voors AA; Lefkowitz MP; Packer M; McMurray JJ; Solomon SD;
    J Am Coll Cardiol; 2014 Feb; 63(5):447-56. PubMed ID: 24184245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left atrial function in heart failure with mid-range ejection fraction differs from that of heart failure with preserved ejection fraction: a 2D speckle-tracking echocardiographic study.
    Al Saikhan L; Hughes AD; Chung WS; Alsharqi M; Nihoyannopoulos P
    Eur Heart J Cardiovasc Imaging; 2019 Mar; 20(3):279-290. PubMed ID: 30517648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Left Atrial Function on Exercise Capacity and Left Ventricular Function in Patients With Heart Failure and Preserved Ejection Fraction.
    von Roeder M; Rommel KP; Kowallick JT; Blazek S; Besler C; Fengler K; Lotz J; Hasenfuß G; Lücke C; Gutberlet M; Schuler G; Schuster A; Lurz P
    Circ Cardiovasc Imaging; 2017 Apr; 10(4):. PubMed ID: 28360259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ST2 in heart failure with preserved and reduced ejection fraction.
    Najjar E; Faxén UL; Hage C; Donal E; Daubert JC; Linde C; Lund LH
    Scand Cardiovasc J; 2019 Feb; 53(1):21-27. PubMed ID: 30776920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left atrial systolic and diastolic dysfunction in heart failure with normal left ventricular ejection fraction.
    Morris DA; Gailani M; Vaz Pérez A; Blaschke F; Dietz R; Haverkamp W; Ozcelik C
    J Am Soc Echocardiogr; 2011 Jun; 24(6):651-62. PubMed ID: 21458230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Utility and Clinical Significance of Cardiac Mechanics in Heart Failure With Preserved Ejection Fraction: Importance of Left Atrial Strain.
    Freed BH; Daruwalla V; Cheng JY; Aguilar FG; Beussink L; Choi A; Klein DA; Dixon D; Baldridge A; Rasmussen-Torvik LJ; Maganti K; Shah SJ
    Circ Cardiovasc Imaging; 2016 Mar; 9(3):. PubMed ID: 26941415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased atrial contribution to left ventricular filling compensates for impaired early filling during exercise in heart failure with preserved ejection fraction.
    Phan TT; Abozguia K; Shivu GN; Ahmed I; Leyva F; Patel K; Frenneaux M
    J Card Fail; 2009 Dec; 15(10):890-7. PubMed ID: 19944366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left atrial function measured by cardiac magnetic resonance imaging in patients with heart failure: clinical associations and prognostic value.
    Pellicori P; Zhang J; Lukaschuk E; Joseph AC; Bourantas CV; Loh H; Bragadeesh T; Clark AL; Cleland JG
    Eur Heart J; 2015 Mar; 36(12):733-42. PubMed ID: 25336215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of subclinical left ventricular dysfunction in heart failure with preserved ejection fraction: The PARAGON-HF study.
    Minamisawa M; Inciardi RM; Claggett B; Cikes M; Liu L; Prasad N; Biering-Sørensen T; Lam CSP; Shah SJ; Zile MR; O'Meara E; Redfield MM; McMurray JJV; Solomon SD; Shah AM
    Eur J Heart Fail; 2024 Apr; 26(4):871-881. PubMed ID: 38369856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left Atrial Dysfunction as an Independent Correlate of Heart Failure Symptoms in Patients With Severe Aortic Stenosis and Preserved Left Ventricular Ejection Fraction.
    Mateescu AD; Călin A; Beladan CC; Roşca M; Enache R; Băicuş C; Botezatu S; Ginghină C; Popescu BA
    J Am Soc Echocardiogr; 2019 Feb; 32(2):257-266. PubMed ID: 30717861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing heart failure with preserved and reduced ejection fraction: An imaging and plasma biomarker approach.
    Kanagala P; Arnold JR; Singh A; Chan DCS; Cheng ASH; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
    PLoS One; 2020; 15(4):e0232280. PubMed ID: 32349122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left atrial function predicts heart failure hospitalization in subjects with preserved ejection fraction and coronary heart disease: longitudinal data from the Heart and Soul Study.
    Welles CC; Ku IA; Kwan DM; Whooley MA; Schiller NB; Turakhia MP
    J Am Coll Cardiol; 2012 Feb; 59(7):673-80. PubMed ID: 22322084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of ST2 and B-type natriuretic peptide in diabetic patients with acute heart failure: relation with ventricular stiffness and outcome.
    Ruocco G; Evangelista I; Franci B; Lucani B; Martini S; Nuti R; Palazzuoli A
    J Cardiovasc Med (Hagerstown); 2019 Feb; 20(2):81-90. PubMed ID: 30540645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline characteristics of patients with heart failure and preserved ejection fraction included in the Karolinska Rennes (KaRen) study.
    Donal E; Lund LH; Oger E; Hage C; Persson H; Reynaud A; Ennezat PV; Bauer F; Sportouch-Dukhan C; Drouet E; Daubert JC; Linde C;
    Arch Cardiovasc Dis; 2014 Feb; 107(2):112-21. PubMed ID: 24388161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New echocardiographic predictors of clinical outcome in patients presenting with heart failure and a preserved left ventricular ejection fraction: a subanalysis of the Ka (Karolinska) Ren (Rennes) Study.
    Donal E; Lund LH; Oger E; Hage C; Persson H; Reynaud A; Ennezat PV; Bauer F; Drouet E; Linde C; Daubert C;
    Eur J Heart Fail; 2015 Jul; 17(7):680-8. PubMed ID: 26033771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction.
    Melenovsky V; Hwang SJ; Redfield MM; Zakeri R; Lin G; Borlaug BA
    Circ Heart Fail; 2015 Mar; 8(2):295-303. PubMed ID: 25593126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of arginine vasopressin with low atrial natriuretic peptide levels, left ventricular remodelling, and outcomes in adults with and without heart failure.
    Chirinos JA; Sardana M; Oldland G; Ansari B; Lee J; Hussain A; Mustafa A; Akers SR; Wei W; Lakatta EG; Fedorova OV
    ESC Heart Fail; 2018 Oct; 5(5):911-919. PubMed ID: 29969536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.
    Santhanakrishnan R; Chong JP; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Richards AM; Lam CS
    Eur J Heart Fail; 2012 Dec; 14(12):1338-47. PubMed ID: 22869458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.